Serum Fibroblast Growth Factor 19 and Total Bile Acid Concentrations Are Potential Biomarkers of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus

Table 3

Multivariable regression analysis of various biomarkers versus FGF19.

	Control		T2DM		HCC		T2DM-HCC
	Standard β		Standard β		Standard β		Standard β
Model 1
TBA	0.397	0.040	0.400	0.039	0.562	0.024	0.701	0.024
Model 2
TBA	0.414	0.031	0.461	0.032	0.637	0.037	0.826	0.044

Model 1: crude model without covariate adjustment; model 2: adjustment for age, SBP, FPG, and CEA. Control: healthy control; T2DM: newly diagnosed type 2 diabetes mellitus patients; HCC: newly diagnosed hepatocellular carcinoma patients; T2DM-HCC: type 2 diabetes mellitus combined newly diagnosed hepatocellular carcinoma patients. Abbreviations are same as in Table 1.